These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 35504814)

  • 21. Idiopathic pulmonary fibrosis in small cell lung cancer as a predictive factor for poor clinical outcome and risk of its exacerbation.
    Koyama N; Iwai Y; Nagai Y; Aoshiba K; Nakamura H
    PLoS One; 2019; 14(8):e0221718. PubMed ID: 31442290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics and evaluation of acute exacerbations in chronic interstitial lung diseases.
    Kershaw CD; Batra K; Torrealba JR; Terada LS
    Respir Med; 2021 Jul; 183():106400. PubMed ID: 33957435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis.
    Englert JM; Hanford LE; Kaminski N; Tobolewski JM; Tan RJ; Fattman CL; Ramsgaard L; Richards TJ; Loutaev I; Nawroth PP; Kasper M; Bierhaus A; Oury TD
    Am J Pathol; 2008 Mar; 172(3):583-91. PubMed ID: 18245812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
    Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
    Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
    de Lauretis A; Veeraraghavan S; Renzoni E
    Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute exacerbation of interstitial lung disease associated with rheumatic disease.
    Luppi F; Sebastiani M; Salvarani C; Bendstrup E; Manfredi A
    Nat Rev Rheumatol; 2022 Feb; 18(2):85-96. PubMed ID: 34876670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C
    Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ATS/ERS/JRS/ALAT statement "IPF by HRCT" could predict acute exacerbation of interstitial lung disease in non-small cell lung cancer.
    Asai N; Katsuda E; Hamanaka R; Kosaka K; Matsubara A; Nishimura M; Tanaka H; Yokoe N; Takahashi A; Yamaguchi E; Kubo A
    Tumori; 2017 Jan; 103(1):60-65. PubMed ID: 27791236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis.
    Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    Respirology; 2020 Mar; 25(3):275-280. PubMed ID: 31270920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
    Singh P; Thakur B; Mohapatra AK; Padhan P
    Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute Exacerbation in Interstitial Lung Disease.
    Leuschner G; Behr J
    Front Med (Lausanne); 2017; 4():176. PubMed ID: 29109947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases.
    Faverio P; Stainer A; Conti S; Madotto F; De Giacomi F; Della Zoppa M; Vancheri A; Pellegrino MR; Tonelli R; Cerri S; Clini EM; Mantovani LG; Pesci A; Luppi F
    Diagnostics (Basel); 2021 Sep; 11(9):. PubMed ID: 34573965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced receptor for advanced glycation end products is associated with α-SMA expression in patients with idiopathic pulmonary fibrosis and mice.
    Baek H; Jang S; Park J; Jang J; Lee J; Hong SH; Kim WJ; Park SM; Yang SR
    Lab Anim Res; 2021 Oct; 37(1):28. PubMed ID: 34600594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases.
    Lee JH; Jang JH; Park JH; Jang HJ; Park CS; Lee S; Kim SH; Kim JY; Kim HK
    PLoS One; 2021; 16(7):e0255365. PubMed ID: 34314462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pursuing Clinical Predictors and Biomarkers for Progression in ILD: Analysis of the Pulmonary Fibrosis Foundation (PFF) Registry.
    Chang SE; Jia G; Gao X; Schiffman C; Gupta S; Wolters P; Neighbors M
    Lung; 2024 Jun; 202(3):269-273. PubMed ID: 38753183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifibrotic properties of receptor for advanced glycation end products in idiopathic pulmonary fibrosis.
    Ding H; Ji X; Chen R; Ma T; Tang Z; Fen Y; Cai H
    Pulm Pharmacol Ther; 2015 Dec; 35():34-41. PubMed ID: 26545872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute exacerbation in interstitial lung disease.
    Alhamad EH; Cal JG; Alrajhi NN; AlBoukai AA
    Ann Thorac Med; 2021; 16(2):178-187. PubMed ID: 34012485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department.
    Jang HJ; Yong SH; Leem AY; Lee SH; Kim SY; Lee SH; Kim EY; Chung KS; Jung JY; Kang YA; Kim YS; Chang J; Park MS
    Sci Rep; 2021 Mar; 11(1):5762. PubMed ID: 33707643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomere length across different UIP fibrotic-Interstitial Lung Diseases: a prospective Greek case-control study.
    Tomos I; Karakatsani A; Manali ED; Kottaridi C; Spathis A; Argentos S; Papiris SA
    Pulmonology; 2022; 28(4):254-261. PubMed ID: 33358512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model.
    Hozumi H; Kono M; Hasegawa H; Kato S; Inoue Y; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
    Respir Res; 2022 Mar; 23(1):57. PubMed ID: 35277175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.